C8 Health

Name: C8 Health
Brand: C8 Health

AI Native

Bridging the gap between evidence and practice, when and where clinicians need it

Est 2021|Valuation $40.8M|Raised $14.8M|11 Ref Customers

LinkedIn 24K|Web traffic 10K|FTEs 46|HQ New York, New York, US

Published Sep 29, 2026

01Common complaints

1. If the organization primarily needs generalized medical evidence summaries rather than internal protocol dissemination — evidence platforms (e.g., UpToDate, DynaMed, ClinicalKey) may be more appropriate. 2. If the primary requirement is policy attestations and regulatory compliance workflows — a dedicated policy management suite may be superior. 3. If procurement requires broad third-party validation on major review platforms before purchase — the vendor has a limited presence on G2/TrustRadius/Gartner Peer Insights in accessible results. 4. If the IT environment is extremely constrained and embedding in Epic/Cerner with mandatory SSO/SCIM is not feasible without substantial IT involvement — confirm technical feasibility, pilot scope, timeline, and costs early. 5. If budget constraints favor maintaining content within existing intranet solutions (e.g., SharePoint) and rigorous governance can meet the organization’s needs without an additional platform. **Publicly visible limitations (based on available data)** - Limited independent review footprint: The vendor has few or no public listings on major review platforms (G2/TrustRadius/Gartner Peer Insights) in accessible results, reducing third-party corroboration. - Security documentation not fully public in accessible sources: While SOC 2 is claimed, Trust Center details were not accessible in this research environment. - Pricing opacity: No public pricing tiers are published. - Integration specifics not publicly documented: The vendor states integrations with EHRs, scheduling, and LMS systems, but detailed integration documentation is not published in accessible help pages. **Roadmap / change history signals** - The vendor maintains a changelog referencing a rebranding from HeadToToe to C8 Health, indicating product evolution and legacy naming in some app listings. (https://c8health.com/change-log/) - iOS release notes indicate ongoing updates (e.g., quality intervention features in mid-2025). (https://apps.apple.com/ua/app/c8-health/id1534264609)

Deal disqualifiers (poor fit)

Organizations with minimal protocol variation or those that already have highly effective EMR-integrated decision support.
Procurement processes that require extensive third-party validation (external reviews or industry analyst reports) before engagement.

Why customers might leave or decline purchase (evidence constraints)

No robust third-party review corpus was available publicly, so churn reasons are speculative. Likely deal-breakers, based on category norms, include:
- Security review hurdles (SOC 2 scope, BAA terms).
- Integration friction with major EHRs (Epic, Cerner).
- Governance burden: maintaining current protocols is resource-intensive.
- Pricing or contracting constraints compared with existing intranet or EMR solutions.

02Why they buy

**Potential unique selling points (as described in vendor materials)** - Focus on operationalizing locally approved best practices rather than only serving as a document repository. - Web and mobile access designed to surface institution-specific guidance at the point of care, plus an AI-assisted discovery tool that the vendor presents as an aid to searching approved content. - Vendor-published deployment and adoption benchmarks for select customers (buyers should validate these metrics). **Differentiation notes** - The vendor states it can be configured to avoid processing PHI and indicates SOC 2/GDPR/HIPAA compliance; if validated, these aspects can reduce compliance friction for knowledge tools used in clinical environments. - Competitors may have advantages in evidence curation (e.g., UpToDate) or in policy attestation workflows (e.g., PolicyStat).

03Field reports

What’s missing vs typical enterprise software research

- Gartner Peer Insights: No accessible C8 Health product listing surfaced during this research. If a listing exists, it may not be indexed or may be restricted. - G2 / TrustRadius / Capterra / PeerSpot: No clear product listing for "C8 Health" was found on these review platforms in accessible search results. This absence is a market signal: the product may be early-stage in broad SaaS review ecosystems or it may sell via healthcare channels where public reviews are less common.

Vendor-published testimonials (context noted)

The vendor publishes endorsements on its homepage, including a comment attributed to Dr. Keith Loud (Dartmouth Health Children’s) noting that other information and knowledge management systems are difficult to access in real time and that the C8 Health platform provided substantially easier access. These testimonials are selected and vendor-published, and they are not independently verified.

Community/social discussions (limitations)

Searches for "C8 Health reddit" primarily returned unrelated results due to keyword collisions (e.g., references to C8 MCT oil). No substantive Reddit or Hacker News discussions about the C8 Health enterprise platform were found in accessible results.

App store signals (limited)

The iOS listing shows a recent release note describing feature updates such as a quality intervention feature. App store pages for B2B apps often contain limited public narrative reviews because usage is gated by institutional accounts. (Official vendor iOS app store listing)
The Google Play listing appears under legacy branding; detailed review sentiment was not captured in available snippets. (Official vendor Google Play listing)

Inferred reasons customers choose the product (from vendor materials)

Faster retrieval of institution-specific, approved guidance (vendor-published median time-to-access metrics are cited in case studies).
Consolidation of locally approved protocols to reduce fragmented clinical knowledge across portals/folders/emails.
Mobile and web access designed to support point-of-care use.

1) Geneva University Hospitals (HUG) — COVID-era knowledge dissemination

**Source**: Vendor case study page (vendor-published) - Context: Large Swiss hospital system needed rapid dissemination of evolving COVID guidance. - Reported results (vendor-published): - A substantial number of clinicians accessed the platform. - In the initial period, several dozen guidance items were viewed thousands of times. - The case study reports active usage by staff members on COVID wards during the analysis period. - Reported median time to access guidance was measured in seconds. - The vendor-reported implementation timeframe was operational within a day with limited reported IT involvement. **Critical evaluation** - Usage and access metrics are notable, but the public case study does not demonstrate a causal link between platform usage and improved patient outcomes. - The COVID context is atypical and likely increased urgency and engagement relative to steady-state operations. (Source: Vendor case study page)

2) Adoption/engagement summary (vendor PDF)

**Source**: Vendor PDF - Vendor claims: strong adoption within the first year (with much of that adoption occurring in the initial months); average sessions per device and per clinician cited; and minimal formal onboarding for frontline users. **Critical evaluation** - Methodology is not specified: denominators for adoption, session definitions, and included organizations are not documented in the public PDF. Buyers should request the underlying dataset definitions and sample composition if relying on these benchmarks. (Source: Vendor whitepaper / PDF)

3) MetroHealth — referenced outcomes (vendor-distributed)

**Source**: Vendor materials and event pages - Vendor materials and event pages reference MetroHealth outcomes (e.g., access time improvements and staff satisfaction increases). The detailed supporting documentation was not retrieved from an independent outlet in this research. **Critical evaluation** - Vendor social posts and event materials are useful for context but are vendor-controlled distributions and should be corroborated where possible. (Source: Vendor social media posts and event pages)

04Best fit

Company sizes

Best fit appears to be:
- Single hospitals through large multi-hospital systems (from medium-sized facilities to very large health systems).
- Academic medical centers and teaching hospitals with frequent rotations, residents, and complex protocols.

Industries/verticals

Acute care hospitals, perioperative services, anesthesiology, and quality improvement programs.

Roles & personas

Decision makers: CMIO, CNIO, Chief Quality Officer, perioperative leadership, department chairs, clinical operations, patient safety, and QI leaders.
End users: Attending physicians, residents/fellows, nurses, APPs, and pharmacists (depending on scope).

Pain points addressed

Institution-specific protocols exist but are difficult to find quickly.
Clinical guidance is scattered across multiple portals, documents, and emails.
High staff turnover and rotations create frequent onboarding needs.

Qualification criteria (good fit)

Strong internal content owners and governance to keep protocols up-to-date.
A culture receptive to mobile/web-based clinical knowledge tools.
A need to standardize care and improve access to local protocols across sites.

05The pitch

**What the product does (objective value proposition)** - C8 Health is a clinical best-practices implementation and clinical knowledge management platform focused on helping hospitals and clinical departments centralize vetted protocols, disseminate updates, and surface guidance at the point of care via mobile/web access and an AI-assisted search feature ("Panda AI"). The positioning emphasizes implementing locally approved best practices rather than functioning solely as a document repository. (Vendor product overview and feature pages) **Target market & positioning** - Primary buyers and users appear to be hospitals, health systems, physician groups, and clinical departments (e.g., perioperative/anesthesiology, quality improvement teams) seeking faster protocol access, standardization, and reduced fragmentation of clinical knowledge. (Vendor solutions and use-case pages) - The vendor markets itself as a best-practices implementation platform for clinical teams; this vendor claim is not independently validated in public sources. (Vendor website) **Company background (founding year, HQ, leadership)** - Public press indicates C8 Health is based in New York, NY (vendor press materials). (Vendor press release) - LinkedIn lists headquarters as New York, New York and highlights adoption across a sizable number of hospitals. (Vendor LinkedIn company page) - C8’s public privacy notice references C8 Health Inc. (U.S.) and Head ToToe mHealth Sàrl (Geneva, Switzerland) as operating entities doing business as C8 Health, indicating a cross-border corporate structure. (Vendor privacy policy) - External coverage attributes founding to physician/software engineer Ido Zamberg and business leader Galia Rosen-Schwarz (spelling varies by source), with 2022 mentioned in at least one article. Founding-year specifics should be treated as directional unless confirmed on the vendor’s official “About” page. (Third-party press coverage) **Funding & growth** - The vendor announced a recent Series A in vendor/PR-distributed materials and described total funding that includes a prior seed round; these funding specifics are from vendor/PR materials and are not independently audited. (Vendor press release) - Vendor materials state that C8 is addressing care inconsistency at a number of hospitals in the United States; public customer-level proof is selective and primarily vendor-provided. (Vendor press release and product pages) **Pricing model (tiers and costs)** - The public site emphasizes demo requests; public, self-serve pricing is not posted. Expect enterprise quote-based pricing, likely influenced by number of sites/departments/users, implementation scope, and integrations. - Procurement implication: buyers should anticipate an enterprise sales cycle, contracting, security review, and potential multi-year commitments, none of which are publicly documented in detail. **Total cost of ownership (TCO) considerations** - Vendor messaging includes claims that deployments require minimal internal IT involvement and can be completed rapidly; buyers should verify these statements in procurement because practical TCO typically includes: - Content migration and curation work (even if assisted by vendor account management). - Integration effort with EHR/SSO/scheduling/LMS (the vendor states it integrates with such systems, but integration complexity in healthcare is often non-trivial). - Governance and ongoing content ownership (approvals/version control). - Training and change management (vendor materials include case-study summaries that suggest limited onboarding for frontline users; these are vendor-produced and should be validated). **Key competitors / alternatives (4–6)** Because "clinical knowledge management + best-practice implementation" spans multiple categories, competitors vary by buyer intent: 1. OpenEvidence (clinical evidence search) (Vendor product page) 2. UpToDate (Wolters Kluwer) (Official product page) 3. DynaMed (EBSCO) (Official product page) 4. Elsevier ClinicalKey (content platform) (Official product page) 5. PolicyStat (powered by RLDatix) (policy/procedure management) (Vendor product page) 6. General intranet/document & policy platforms (e.g., SharePoint-based KM) that are not healthcare-specific but widely deployed. Note: These alternatives overlap but are not identical. Many are stronger on evidence content, while C8 emphasizes local protocol operationalization.

Get a comprehensive analysis of C8 Health including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →

Published Sep 29, 2026

01Common complaints

If the organization primarily needs generalized medical evidence summaries rather than internal protocol dissemination — evidence platforms (e.g., UpToDate, DynaMed, ClinicalKey) may be more appropriate.
If the primary requirement is policy attestations and regulatory compliance workflows — a dedicated policy management suite may be superior.
If procurement requires broad third-party validation on major review platforms before purchase — the vendor has a limited presence on G2/TrustRadius/Gartner Peer Insights in accessible results.
If the IT environment is extremely constrained and embedding in Epic/Cerner with mandatory SSO/SCIM is not feasible without substantial IT involvement — confirm technical feasibility, pilot scope, timeline, and costs early.
If budget constraints favor maintaining content within existing intranet solutions (e.g., SharePoint) and rigorous governance can meet the organization’s needs without an additional platform.

Publicly visible limitations (based on available data)

Limited independent review footprint: The vendor has few or no public listings on major review platforms (G2/TrustRadius/Gartner Peer Insights) in accessible results, reducing third-party corroboration.
Security documentation not fully public in accessible sources: While SOC 2 is claimed, Trust Center details were not accessible in this research environment.
Pricing opacity: No public pricing tiers are published.
Integration specifics not publicly documented: The vendor states integrations with EHRs, scheduling, and LMS systems, but detailed integration documentation is not published in accessible help pages.

Roadmap / change history signals

The vendor maintains a changelog referencing a rebranding from HeadToToe to C8 Health, indicating product evolution and legacy naming in some app listings. (https://c8health.com/change-log/)
iOS release notes indicate ongoing updates (e.g., quality intervention features in mid-2025). (https://apps.apple.com/ua/app/c8-health/id1534264609)

Deal disqualifiers (poor fit)

Organizations with minimal protocol variation or those that already have highly effective EMR-integrated decision support.
Procurement processes that require extensive third-party validation (external reviews or industry analyst reports) before engagement.

Why customers might leave or decline purchase (evidence constraints)

No robust third-party review corpus was available publicly, so churn reasons are speculative. Likely deal-breakers, based on category norms, include:
- Security review hurdles (SOC 2 scope, BAA terms).
- Integration friction with major EHRs (Epic, Cerner).
- Governance burden: maintaining current protocols is resource-intensive.
- Pricing or contracting constraints compared with existing intranet or EMR solutions.

02Why they buy

Potential unique selling points (as described in vendor materials)

Focus on operationalizing locally approved best practices rather than only serving as a document repository.
Web and mobile access designed to surface institution-specific guidance at the point of care, plus an AI-assisted discovery tool that the vendor presents as an aid to searching approved content.
Vendor-published deployment and adoption benchmarks for select customers (buyers should validate these metrics).

Differentiation notes

The vendor states it can be configured to avoid processing PHI and indicates SOC 2/GDPR/HIPAA compliance; if validated, these aspects can reduce compliance friction for knowledge tools used in clinical environments.
Competitors may have advantages in evidence curation (e.g., UpToDate) or in policy attestation workflows (e.g., PolicyStat).

03Field reports

What’s missing vs typical enterprise software research

Gartner Peer Insights: No accessible C8 Health product listing surfaced during this research. If a listing exists, it may not be indexed or may be restricted.
G2 / TrustRadius / Capterra / PeerSpot: No clear product listing for "C8 Health" was found on these review platforms in accessible search results. This absence is a market signal: the product may be early-stage in broad SaaS review ecosystems or it may sell via healthcare channels where public reviews are less common.

Vendor-published testimonials (context noted)

The vendor publishes endorsements on its homepage, including a comment attributed to Dr. Keith Loud (Dartmouth Health Children’s) noting that other information and knowledge management systems are difficult to access in real time and that the C8 Health platform provided substantially easier access. These testimonials are selected and vendor-published, and they are not independently verified.

Community/social discussions (limitations)

Searches for "C8 Health reddit" primarily returned unrelated results due to keyword collisions (e.g., references to C8 MCT oil). No substantive Reddit or Hacker News discussions about the C8 Health enterprise platform were found in accessible results.

App store signals (limited)

The iOS listing shows a recent release note describing feature updates such as a quality intervention feature. App store pages for B2B apps often contain limited public narrative reviews because usage is gated by institutional accounts. (Official vendor iOS app store listing)
The Google Play listing appears under legacy branding; detailed review sentiment was not captured in available snippets. (Official vendor Google Play listing)

Inferred reasons customers choose the product (from vendor materials)

Faster retrieval of institution-specific, approved guidance (vendor-published median time-to-access metrics are cited in case studies).
Consolidation of locally approved protocols to reduce fragmented clinical knowledge across portals/folders/emails.
Mobile and web access designed to support point-of-care use.

1) Geneva University Hospitals (HUG) — COVID-era knowledge dissemination

Source: Vendor case study page (vendor-published)

Context: Large Swiss hospital system needed rapid dissemination of evolving COVID guidance.
Reported results (vendor-published):
- A substantial number of clinicians accessed the platform.
- In the initial period, several dozen guidance items were viewed thousands of times.
- The case study reports active usage by staff members on COVID wards during the analysis period.
- Reported median time to access guidance was measured in seconds.
- The vendor-reported implementation timeframe was operational within a day with limited reported IT involvement.

Critical evaluation

Usage and access metrics are notable, but the public case study does not demonstrate a causal link between platform usage and improved patient outcomes.
The COVID context is atypical and likely increased urgency and engagement relative to steady-state operations.

(Source: Vendor case study page)

2) Adoption/engagement summary (vendor PDF)

Source: Vendor PDF

Vendor claims: strong adoption within the first year (with much of that adoption occurring in the initial months); average sessions per device and per clinician cited; and minimal formal onboarding for frontline users.

Critical evaluation

Methodology is not specified: denominators for adoption, session definitions, and included organizations are not documented in the public PDF. Buyers should request the underlying dataset definitions and sample composition if relying on these benchmarks.

(Source: Vendor whitepaper / PDF)

3) MetroHealth — referenced outcomes (vendor-distributed)

Source: Vendor materials and event pages

Vendor materials and event pages reference MetroHealth outcomes (e.g., access time improvements and staff satisfaction increases). The detailed supporting documentation was not retrieved from an independent outlet in this research.

Critical evaluation

Vendor social posts and event materials are useful for context but are vendor-controlled distributions and should be corroborated where possible.

(Source: Vendor social media posts and event pages)

04Best fit

Company sizes

Best fit appears to be:
- Single hospitals through large multi-hospital systems (from medium-sized facilities to very large health systems).
- Academic medical centers and teaching hospitals with frequent rotations, residents, and complex protocols.

Industries/verticals

Acute care hospitals, perioperative services, anesthesiology, and quality improvement programs.

Roles & personas

Decision makers: CMIO, CNIO, Chief Quality Officer, perioperative leadership, department chairs, clinical operations, patient safety, and QI leaders.
End users: Attending physicians, residents/fellows, nurses, APPs, and pharmacists (depending on scope).

Pain points addressed

Institution-specific protocols exist but are difficult to find quickly.
Clinical guidance is scattered across multiple portals, documents, and emails.
High staff turnover and rotations create frequent onboarding needs.

Qualification criteria (good fit)

Strong internal content owners and governance to keep protocols up-to-date.
A culture receptive to mobile/web-based clinical knowledge tools.
A need to standardize care and improve access to local protocols across sites.

05The pitch

What the product does (objective value proposition)

C8 Health is a clinical best-practices implementation and clinical knowledge management platform focused on helping hospitals and clinical departments centralize vetted protocols, disseminate updates, and surface guidance at the point of care via mobile/web access and an AI-assisted search feature ("Panda AI"). The positioning emphasizes implementing locally approved best practices rather than functioning solely as a document repository. (Vendor product overview and feature pages)

Target market & positioning

Primary buyers and users appear to be hospitals, health systems, physician groups, and clinical departments (e.g., perioperative/anesthesiology, quality improvement teams) seeking faster protocol access, standardization, and reduced fragmentation of clinical knowledge. (Vendor solutions and use-case pages)
The vendor markets itself as a best-practices implementation platform for clinical teams; this vendor claim is not independently validated in public sources. (Vendor website)

Company background (founding year, HQ, leadership)

Public press indicates C8 Health is based in New York, NY (vendor press materials). (Vendor press release)
LinkedIn lists headquarters as New York, New York and highlights adoption across a sizable number of hospitals. (Vendor LinkedIn company page)
C8’s public privacy notice references C8 Health Inc. (U.S.) and Head ToToe mHealth Sàrl (Geneva, Switzerland) as operating entities doing business as C8 Health, indicating a cross-border corporate structure. (Vendor privacy policy)
External coverage attributes founding to physician/software engineer Ido Zamberg and business leader Galia Rosen-Schwarz (spelling varies by source), with 2022 mentioned in at least one article. Founding-year specifics should be treated as directional unless confirmed on the vendor’s official “About” page. (Third-party press coverage)

Funding & growth

The vendor announced a recent Series A in vendor/PR-distributed materials and described total funding that includes a prior seed round; these funding specifics are from vendor/PR materials and are not independently audited. (Vendor press release)
Vendor materials state that C8 is addressing care inconsistency at a number of hospitals in the United States; public customer-level proof is selective and primarily vendor-provided. (Vendor press release and product pages)

Pricing model (tiers and costs)

The public site emphasizes demo requests; public, self-serve pricing is not posted. Expect enterprise quote-based pricing, likely influenced by number of sites/departments/users, implementation scope, and integrations.
Procurement implication: buyers should anticipate an enterprise sales cycle, contracting, security review, and potential multi-year commitments, none of which are publicly documented in detail.

Total cost of ownership (TCO) considerations

Vendor messaging includes claims that deployments require minimal internal IT involvement and can be completed rapidly; buyers should verify these statements in procurement because practical TCO typically includes:
- Content migration and curation work (even if assisted by vendor account management).
- Integration effort with EHR/SSO/scheduling/LMS (the vendor states it integrates with such systems, but integration complexity in healthcare is often non-trivial).
- Governance and ongoing content ownership (approvals/version control).
- Training and change management (vendor materials include case-study summaries that suggest limited onboarding for frontline users; these are vendor-produced and should be validated).

Key competitors / alternatives (4–6) Because "clinical knowledge management + best-practice implementation" spans multiple categories, competitors vary by buyer intent:

OpenEvidence (clinical evidence search) (Vendor product page)
UpToDate (Wolters Kluwer) (Official product page)
DynaMed (EBSCO) (Official product page)
Elsevier ClinicalKey (content platform) (Official product page)
PolicyStat (powered by RLDatix) (policy/procedure management) (Vendor product page)
General intranet/document & policy platforms (e.g., SharePoint-based KM) that are not healthcare-specific but widely deployed.

Note: These alternatives overlap but are not identical. Many are stronger on evidence content, while C8 emphasizes local protocol operationalization.

Get a comprehensive analysis of C8 Health including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →

If the organization primarily needs generalized medical evidence summaries rather than internal protocol dissemination — evidence platforms (e.g., UpToDate, DynaMed, ClinicalKey) may be more appropriate.
If the primary requirement is policy attestations and regulatory compliance workflows — a dedicated policy management suite may be superior.
If procurement requires broad third-party validation on major review platforms before purchase — the vendor has a limited presence on G2/TrustRadius/Gartner Peer Insights in accessible results.
If the IT environment is extremely constrained and embedding in Epic/Cerner with mandatory SSO/SCIM is not feasible without substantial IT involvement — confirm technical feasibility, pilot scope, timeline, and costs early.
If budget constraints favor maintaining content within existing intranet solutions (e.g., SharePoint) and rigorous governance can meet the organization’s needs without an additional platform.

Publicly visible limitations (based on available data)

Limited independent review footprint: The vendor has few or no public listings on major review platforms (G2/TrustRadius/Gartner Peer Insights) in accessible results, reducing third-party corroboration.
Security documentation not fully public in accessible sources: While SOC 2 is claimed, Trust Center details were not accessible in this research environment.
Pricing opacity: No public pricing tiers are published.
Integration specifics not publicly documented: The vendor states integrations with EHRs, scheduling, and LMS systems, but detailed integration documentation is not published in accessible help pages.

Roadmap / change history signals

The vendor maintains a changelog referencing a rebranding from HeadToToe to C8 Health, indicating product evolution and legacy naming in some app listings. (https://c8health.com/change-log/)
iOS release notes indicate ongoing updates (e.g., quality intervention features in mid-2025). (https://apps.apple.com/ua/app/c8-health/id1534264609)

What the product does (objective value proposition)

C8 Health is a clinical best-practices implementation and clinical knowledge management platform focused on helping hospitals and clinical departments centralize vetted protocols, disseminate updates, and surface guidance at the point of care via mobile/web access and an AI-assisted search feature ("Panda AI"). The positioning emphasizes implementing locally approved best practices rather than functioning solely as a document repository. (Vendor product overview and feature pages)

Target market & positioning

Primary buyers and users appear to be hospitals, health systems, physician groups, and clinical departments (e.g., perioperative/anesthesiology, quality improvement teams) seeking faster protocol access, standardization, and reduced fragmentation of clinical knowledge. (Vendor solutions and use-case pages)
The vendor markets itself as a best-practices implementation platform for clinical teams; this vendor claim is not independently validated in public sources. (Vendor website)

Company background (founding year, HQ, leadership)

Public press indicates C8 Health is based in New York, NY (vendor press materials). (Vendor press release)
LinkedIn lists headquarters as New York, New York and highlights adoption across a sizable number of hospitals. (Vendor LinkedIn company page)
C8’s public privacy notice references C8 Health Inc. (U.S.) and Head ToToe mHealth Sàrl (Geneva, Switzerland) as operating entities doing business as C8 Health, indicating a cross-border corporate structure. (Vendor privacy policy)
External coverage attributes founding to physician/software engineer Ido Zamberg and business leader Galia Rosen-Schwarz (spelling varies by source), with 2022 mentioned in at least one article. Founding-year specifics should be treated as directional unless confirmed on the vendor’s official “About” page. (Third-party press coverage)

Funding & growth

The vendor announced a recent Series A in vendor/PR-distributed materials and described total funding that includes a prior seed round; these funding specifics are from vendor/PR materials and are not independently audited. (Vendor press release)
Vendor materials state that C8 is addressing care inconsistency at a number of hospitals in the United States; public customer-level proof is selective and primarily vendor-provided. (Vendor press release and product pages)

Pricing model (tiers and costs)

The public site emphasizes demo requests; public, self-serve pricing is not posted. Expect enterprise quote-based pricing, likely influenced by number of sites/departments/users, implementation scope, and integrations.
Procurement implication: buyers should anticipate an enterprise sales cycle, contracting, security review, and potential multi-year commitments, none of which are publicly documented in detail.

Total cost of ownership (TCO) considerations

Vendor messaging includes claims that deployments require minimal internal IT involvement and can be completed rapidly; buyers should verify these statements in procurement because practical TCO typically includes:
- Content migration and curation work (even if assisted by vendor account management).
- Integration effort with EHR/SSO/scheduling/LMS (the vendor states it integrates with such systems, but integration complexity in healthcare is often non-trivial).
- Governance and ongoing content ownership (approvals/version control).
- Training and change management (vendor materials include case-study summaries that suggest limited onboarding for frontline users; these are vendor-produced and should be validated).

Key competitors / alternatives (4–6) Because "clinical knowledge management + best-practice implementation" spans multiple categories, competitors vary by buyer intent:

OpenEvidence (clinical evidence search) (Vendor product page)
UpToDate (Wolters Kluwer) (Official product page)
DynaMed (EBSCO) (Official product page)
Elsevier ClinicalKey (content platform) (Official product page)
PolicyStat (powered by RLDatix) (policy/procedure management) (Vendor product page)
General intranet/document & policy platforms (e.g., SharePoint-based KM) that are not healthcare-specific but widely deployed.

Note: These alternatives overlap but are not identical. Many are stronger on evidence content, while C8 emphasizes local protocol operationalization.